ME/CFS Research Summaries

Tag: ➕-2026-03-08✕

8 items with this tag.

  • Mar 06, 2026

    ACHTSAM study protocol: outreach diagnostics and assessment of tolerability in severe ME/CFS-a pilot study

    • ➕-2026-03-08
    • 🧪-Biomarker
    • ⏳-Trial
  • Mar 06, 2026

    Long COVID neuropathy: The role of mast cells

    • ➕-2026-03-08
    • 💊-Treatment
    • 🧪-Biomarker
  • Mar 04, 2026

    Charting the circulating proteome in ME/CFS using cross-system profiling to uncover mechanistic insights

    • ➕-2026-03-08
    • ⭐-Landmark
    • 🧪-Biomarker
  • Mar 04, 2026

    Molecular Hydrogen as a Treatment for ME/CFS: A Mini-Review of Clinical Evidence and Mechanistic Rationale

    • ➕-2026-03-08
    • 💊-Treatment
  • Mar 03, 2026

    Assessment and Incidence Determination of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Following a SARS-CoV-2 Infection in a Prospective Cohort of Hospital Employees

    • ➕-2026-03-08
    • 🧪-Biomarker
  • Mar 02, 2026

    Microbiota-derived extracellular vesicles link intestinal dysbiosis to neuroimmune activation in long COVID

    • ➕-2026-03-08
    • 🧪-Biomarker
  • Mar 01, 2026

    Pipeline-optimized machine learning for chronic fatigue syndrome diagnosis: A lightweight, interpretable model using blood biochemical and metabolomic data

    • ➕-2026-03-08
    • ⭐-Landmark
    • 🧪-Biomarker
  • Feb 28, 2026

    Extracellular Vesicle Protein and MiRNA Signatures as Biomarkers for Post-Infectious ME/CFS Patients

    • ➕-2026-03-08
    • 🧪-Biomarker

Created with Quartz v4.5.2 © 2026

  • Home
  • GitHub
  • Imprint